SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001021408-01-508839
Filing Date
2001-10-26
Accepted
2001-10-26 00:00:00
Documents
11
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 62939
3 AMENDED AND RESTATED 1991 EQUITY INCENTIVE PLAN dex101.txt EX-10.1 48558
4 AMENDED AND RESTATED 1997 SPECIAL NON-OFFICER PLAN dex1040.txt EX-10.40 36467
5 SECOND AMENDMENT TO AMGEN RETIREMENT PLAN dex1053.txt EX-10.53 15752
6 SECOND AMENDMENT TO AMGEN CHANGE OF CONTROL PLAN dex1054.txt EX-10.54 3522
7 FIRST AMEND TO AMGEN SUPP RETIREMENT PLAN dex1055.txt EX-10.55 1556
8 AGREEMENT WITH DR. GEORGE MORSTYN dex1056.txt EX-10.56 73063
9 PROMISSORY NOTE OF BRIAN MCNAMEE dex1057.txt EX-10.57 11184
10 RESTRICTED STOCK PURCHASE AGREEMENT WITH RICHARD NANULA dex1058.txt EX-10.58 11651
11 RESTRICTED STOCK PURCHASE AGREEMENT WITH ROGER PERLMUTTER dex1059.txt EX-10.59 10102
12 FACTORS THAT MAY AFFECT AMGEN dex99.txt EX-99 19394
  Complete submission text file 0001021408-01-508839.txt   296780
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 1767551
SIC: 2836 Biological Products, (No Diagnostic Substances)